كلية الطب البشري

المزيد ...

حول كلية الطب البشري

لقد تم تأسيس كلية الطب البشري في سنة 1973م، بمدينة طرابلس لتقوم بدورها المنوط بها والمتمثل في تخريج الكوادر الطبية المؤهلة، وفي سنة 1980م تم تخريج أول دفعة منها.

تعد كلية الطب البشري من أكبر كليات الجامعة وصرحاً من صروح المعرفة، بحيث أسهمت هذه الكلية خلال العقود الأربعة الماضية في إعداد وتخريج أطباء مؤهلين كان لهم الفضل بعد الله تعالى في إنجاح العمل الطبي من خلال المستشفيات المنتشرة في ربوع الوطن الحبيب لتقديم أفضل الخدمات الصحية، تضم كلية الطب البشري حالياً أكثر من 493 عضو هيئة تدريس جُلهم من العناصر الوطنية الذين كانوا من أوائل الدفعات في هذه الكلية والذين ساهموا في تقديم الخدمات الصحية اللازمة في المستشفيات والعيادات والمستوصفات.

قد تم إيفاد العديد من خريجي هذه الكلية لاستكمال دراستهم في الخارج والذين أثبتوا جدارتهم في التحصيل العلمي والسريري بشهادة العديد من الجامعات العالمية، هذا وفي الوقت الذي تسعي فيه الكلية لتفعيل برنامج الدراسات العليا في مختلف التخصصات فإنها تعمل علي تطوير مفردات مناهجها وطرق التدريس المواكبة لمتطلبات الجودة العالمية.

حقائق حول كلية الطب البشري

نفتخر بما نقدمه للمجتمع والعالم

80

المنشورات العلمية

238

هيئة التدريس

7385

الطلبة

0

الخريجون

البرامج الدراسية

درجة ماجستير
تخصص طب الأسرة والمجتمع

قريباً...

التفاصيل
المقرر الدراسي
تخصص طب الأطفالPD480

A twelve week rotation. Five weeks at Tripoli children hospital, rotating in the inpatient and outpatient departments.One week at the pediatric department –Tajoura hospital. Five weeks at Tripoli medical center, one week at university.Emphasis is on acquiring skills, and medical knowledge to be able...

التفاصيل

من يعمل بـكلية الطب البشري

يوجد بـكلية الطب البشري أكثر من 238 عضو هيئة تدريس

staff photo

د. طارق ابراهيم نجيب الأثرم

- M.B.CH. B Date: April 1997 - Libyan board in Orthopedic 30th June 2004 - European spine Diploma, 2012. - Short Fellowship in spine surgery India 2008 - Short Fellowship in Spine surgery Hongkong 2010

منشورات مختارة

بعض المنشورات التي تم نشرها في كلية الطب البشري

Risk calculation of developing type 2 diabetes in Libyan adults

The aim of this study was to identify nationals at risk of developing type 2 diabetes within the next 10 years in some areas across Tripoli Health Authority in Libya. In this questionnaire‐based survey, a total of 400 Libyan nationals of both genders were randomly selected from seven areas across the central area of Tripoli Health Authority (Soug El‐Juma, Zawet Dahmani, Al‐Furnaj, Ain Zara, Al‐Madena Centre, Al‐Dhahra Centre, and Noflean). All participants approached (400) completed the study and responded to the items of the survey. Based on a modified Finnish Type 2 Diabetes Risk Score test (FINDRISC), 129 (32.3%) were categorised as either at moderate or at high/very high risk of developing diabetes within the next 10 years of life. Among the 129 participants at risk, body mass index was >25 kg/m2 in 125 (96.9%) and waist circumferences were high (>88 cm for females;>102 cm for males) in almost 45% of the women and 22% of the men. We found that in the sample studied the risk of developing diabetes was clear, and there is no doubt that interventions to reduce such risk are a priority rather than a need. Diabetes has a great impact on the health of the nation and also on the future resources of the country in managing the disease and its complications; a health education/health campaign could be one good answer to tackle the problem. arabic 9 English 54
Hawa Juma El-Shareif(6-2009)
Publisher's website

Anti-Angiogenic Effect of Cantharellus cibarius Extracts, its Correlation with Lipoxygenase Inhibition, and Role of the Bioactives Therein

Angiogenesis is a complex physiological process that cannot be treated with single agent therapy. Several edible fungi have been known to encompass bioactive compounds, and are promising sources of multi-component drugs. One such widely consumed edible fungi is Cantharellus cibarius, which has been explored for its biological activities. The present study focused on assessing the anti-angiogenic activity of petroleum ether and ethanol extracts of C. cibarius using chick chorioallantoic membrane (CAM) assay. Both the extracts showed a dose-dependent response which was compared with the anti-angiogenic activity of the positive controls silibinin, and lenalidomide. The extracts were also studied for their lipoxygenase (LOX) inhibitory potential and compared to ascorbic acid as the positive control. The IC50 values of the petroleum ether extract, ethanol extract, and ascorbic acid for LOX inhibition assay were 135.4, 113.1, and 41.5 mg/mL, respectively. Although both the extracts showed similar responses in CAM assay, ethanol extract proved to be more potent in LOX inhibition assay. Finally, the extracts were investigated for their chemical composition using GC-MS. A correlation between LOX inhibition and anti-angiogenic potential was established at the molecular level. A meticulous literature search was carried out to correlate the biochemical composition of the extracts to their anti-angiogenic activity arabic 19 English 119
Sandesh J. Marathe, Abdulla Bashein(1-2021)
Publisher's website

Problem facing us in casualty and Opds

Opinion Cough in kids less than 6yrs old whether being with sputum i.e. wet or without i.e. dry and parental asking about any medicine stopping this symptom certainly if being dry i.e. irritating and disturbing sleep. So most studies being done on this subject proved the following: a) It is not wise to suppress cough because it is natural defense mechanism to expel infected mucus i.e. sputum out of the body and clearing the airways to improve oxygenation so never to prescribe antitussive i.e. cough suppressant. b) sputum mucolytic agents and there are many agents their purpose to liquify it and get it watery to be easy expectorated again studies proved that the best muculytic agent is Good Hydration so no need to use except where there is a mucus retention in the lungs like case of brocheictasis. c) WHO recommendation made about 6 yrs back was never to prescribe any cough medicine whether antitussive or mucolytic to kids less than 6 yrs old. Myself and since about 10 years I had not prescribed any cough suppressant to children despite of age but if kids older than 6 years old I do prescribe mucolytic agent made certainly for kids like amydramine syrup which contains antihistamine diphenhydramine and without restrictions. In kids less than 6yrs old again I do prescribe mucolytic made for kids like soolan or Amydramine pediatric syrup in trial to hit 2 birds which are sedating and antihistamine effects and satisfying anxious parents and it does work almost in all cases arabic 6 English 32
Hisham Mukhtar Alhaashimi Alrabty(5-2017)
Publisher's website